Cite
HARVARD Citation
Palma, D. et al. (2021). Should stereotactic radiotherapy be the preferred treatment for oligometastatic disease?. Lancet oncology. 22 (8), pp. 1067-1068. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Palma, D. et al. (2021). Should stereotactic radiotherapy be the preferred treatment for oligometastatic disease?. Lancet oncology. 22 (8), pp. 1067-1068. [Online].